Search research articles
Contact Us
Filters
Showing results (31-40 of 42) with videos related to
Page
of 5
Sort By:
Journal of Molecular Medicine (Berlin, Germany)
|
February 14, 2008
A new microtubule-targeting compound PBOX-15 inhibits T-cell migration via post-translational modifications of tubulin
Navin K Verma, Eugene Dempsey, Jennifer Conroy, et al.
Molecules (Basel, Switzerland)
|
December 23, 2023
Synthesis and Pro-Apoptotic Effects of Nitrovinylanthracenes and Related Compounds in Chronic Lymphocytic Leukaemia (CLL) and Burkitt's Lymphoma (BL)
Andrew J Byrne, Sandra A Bright, James P McKeown, et al.
Life Sciences
|
December 26, 2021
A novel aryl-guanidinium derivative, VP79s, targets the signal transducer and activator of transcription 3 signaling pathway, downregulates myeloid cell leukaemia-1 and exhibits preclinical activity against multiple myeloma
Rebecca Amet, Viola Previtali, Helene B Mihigo, et al.
Pharmaceuticals (Basel, Switzerland)
|
August 29, 2024
Synthesis and Biochemical Evaluation of Ethanoanthracenes and Related Compounds: Antiproliferative and Pro-Apoptotic Effects in Chronic Lymphocytic Leukemia (CLL)
James P McKeown, Andrew J Byrne, Sandra A Bright, et al.
Cancer Research
|
October 15, 2009
The novel tubulin-targeting agent pyrrolo-1,5-benzoxazepine-15 induces apoptosis in poor prognostic subgroups of chronic lymphocytic leukemia
Anthony M McElligott, Elaina N Maginn, Lisa M Greene, et al.
Plos One
|
April 20, 2026
Upregulation of CD1d and ULBP3 on B cells from healthy donors and chronic lymphocytic leukaemia patients does not prime them for killing by γδ T cells
Julie David, Amy Walsh, Ke Sin Seow, et al.
British Journal of Cancer
|
December 24, 2010
PBOX-15, a novel microtubule targeting agent, induces apoptosis, upregulates death receptors, and potentiates TRAIL-mediated apoptosis in multiple myeloma cells
E N Maginn, P V Browne, P Hayden, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society
|
February 25, 2026
Impact of CD19 CAR T-Cell Therapy on Pathogen-Specific Antibody Titers in Lymphoma Patients
Hayley Foy-Stones, Nicola Gardiner, Ellen Walsh, et al.
British Journal of Haematology
|
November 16, 2021
Epidemiology of chronic lymphocytic leukaemia in an Irish subpopulation with total case ascertainment: an additional tool for health economic planning
Carmel Waldron, David O'Brien, Sarah Brophy, et al.
European Journal of Haematology
|
July 1, 2022
Low CD49d expression in newly diagnosed chronic lymphocytic leukaemia may be associated with high-risk features and reduced treatment-free-intervals
Smyth Elizabeth, Kelly Aidan, O' Brien David, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 42) with videos related to
Sort By:
Page
of 5
Journal of Molecular Medicine (Berlin, Germany)
|
February 14, 2008
A new microtubule-targeting compound PBOX-15 inhibits T-cell migration via post-translational modifications of tubulin
Navin K Verma, Eugene Dempsey, Jennifer Conroy, et al.
Molecules (Basel, Switzerland)
|
December 23, 2023
Synthesis and Pro-Apoptotic Effects of Nitrovinylanthracenes and Related Compounds in Chronic Lymphocytic Leukaemia (CLL) and Burkitt's Lymphoma (BL)
Andrew J Byrne, Sandra A Bright, James P McKeown, et al.
Life Sciences
|
December 26, 2021
A novel aryl-guanidinium derivative, VP79s, targets the signal transducer and activator of transcription 3 signaling pathway, downregulates myeloid cell leukaemia-1 and exhibits preclinical activity against multiple myeloma
Rebecca Amet, Viola Previtali, Helene B Mihigo, et al.
Pharmaceuticals (Basel, Switzerland)
|
August 29, 2024
Synthesis and Biochemical Evaluation of Ethanoanthracenes and Related Compounds: Antiproliferative and Pro-Apoptotic Effects in Chronic Lymphocytic Leukemia (CLL)
James P McKeown, Andrew J Byrne, Sandra A Bright, et al.
Cancer Research
|
October 15, 2009
The novel tubulin-targeting agent pyrrolo-1,5-benzoxazepine-15 induces apoptosis in poor prognostic subgroups of chronic lymphocytic leukemia
Anthony M McElligott, Elaina N Maginn, Lisa M Greene, et al.
Plos One
|
April 20, 2026
Upregulation of CD1d and ULBP3 on B cells from healthy donors and chronic lymphocytic leukaemia patients does not prime them for killing by γδ T cells
Julie David, Amy Walsh, Ke Sin Seow, et al.
British Journal of Cancer
|
December 24, 2010
PBOX-15, a novel microtubule targeting agent, induces apoptosis, upregulates death receptors, and potentiates TRAIL-mediated apoptosis in multiple myeloma cells
E N Maginn, P V Browne, P Hayden, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society
|
February 25, 2026
Impact of CD19 CAR T-Cell Therapy on Pathogen-Specific Antibody Titers in Lymphoma Patients
Hayley Foy-Stones, Nicola Gardiner, Ellen Walsh, et al.
British Journal of Haematology
|
November 16, 2021
Epidemiology of chronic lymphocytic leukaemia in an Irish subpopulation with total case ascertainment: an additional tool for health economic planning
Carmel Waldron, David O'Brien, Sarah Brophy, et al.
European Journal of Haematology
|
July 1, 2022
Low CD49d expression in newly diagnosed chronic lymphocytic leukaemia may be associated with high-risk features and reduced treatment-free-intervals
Smyth Elizabeth, Kelly Aidan, O' Brien David, et al.
Page
of 5